Crossmark

Myeloperoxidase and its negative relationship with cholesterol efflux capacity in patients with psoriasis: results from an observational cohort study

Published Online: 2023-10-20

Authors

Florida, Elizabeth M.

Li, Haiou

Rodante, J.

Teague, H. L.

Playford, Martin P. https://orcid.org/0000-0002-5571-7266
Funding

Funding for this research was provided by:

NHLBI Division of Intramural Research (HL006193-07)
License Information

Text and Data Mining valid from 2023-10-20

Version of Record valid from 2023-10-20
More Information

Article History

Received: 4 September 2023

Accepted: 5 September 2023

First Online: 20 October 2023

Declarations

:

: The cohort of participants was selected using patients from the Psoriasis Atherosclerosis Cardiometabolic Disease Initiative (PACI: NCT01778569), January 2013 through November 2022. All participants provided written, informed consent, and the study protocols were approved by the institutional review board at the National Institutes of Health (NIH) following the Declaration of Helsinki.

: All authors approved the submitted version.

: The authors declare that they have no competing interests.

Document is current